Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. It focuses in developing barium contrast radiographic suspension products for the pharmaceutical industry. The company was founded by Brent Willis on July 23, 2008 and is headquartered in Calgary, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company